vs
Side-by-side financial comparison of FIRST COMMONWEALTH FINANCIAL CORP (FCF) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
FIRST COMMONWEALTH FINANCIAL CORP is the larger business by last-quarter revenue ($133.7M vs $123.8M, roughly 1.1× NATURES SUNSHINE PRODUCTS INC). FIRST COMMONWEALTH FINANCIAL CORP runs the higher net margin — 28.1% vs 3.3%, a 24.8% gap on every dollar of revenue. On growth, FIRST COMMONWEALTH FINANCIAL CORP posted the faster year-over-year revenue change (13.0% vs 4.7%). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 5.5%).
First Commonwealth Financial Corp is a Pennsylvania-based regional financial services holding company. It offers consumer and commercial banking products, loans, wealth management, and insurance services for individuals, small and mid-sized enterprises across central and western Pennsylvania and Ohio.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
FCF vs NATR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $133.7M | $123.8M |
| Net Profit | $37.5M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | — | 4.3% |
| Net Margin | 28.1% | 3.3% |
| Revenue YoY | 13.0% | 4.7% |
| Net Profit YoY | 14.8% | 1379.4% |
| EPS (diluted) | $0.37 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $133.7M | — | ||
| Q4 25 | $137.9M | $123.8M | ||
| Q3 25 | $136.0M | $128.3M | ||
| Q2 25 | $131.0M | $114.8M | ||
| Q1 25 | $118.0M | $113.2M | ||
| Q4 24 | $120.4M | $118.2M | ||
| Q3 24 | $121.2M | $114.6M | ||
| Q2 24 | $120.2M | $110.6M |
| Q1 26 | $37.5M | — | ||
| Q4 25 | $44.9M | $4.1M | ||
| Q3 25 | $41.3M | $5.3M | ||
| Q2 25 | $33.4M | $5.3M | ||
| Q1 25 | $32.7M | $4.7M | ||
| Q4 24 | $35.8M | $-321.0K | ||
| Q3 24 | $32.1M | $4.3M | ||
| Q2 24 | $37.1M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% |
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | 4.3% | ||
| Q3 25 | 38.1% | 7.0% | ||
| Q2 25 | 32.1% | 3.7% | ||
| Q1 25 | 34.8% | 5.4% | ||
| Q4 24 | 37.1% | 3.8% | ||
| Q3 24 | 33.4% | 4.6% | ||
| Q2 24 | 38.7% | 5.1% |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 32.5% | 3.3% | ||
| Q3 25 | 30.4% | 4.2% | ||
| Q2 25 | 25.5% | 4.6% | ||
| Q1 25 | 27.7% | 4.2% | ||
| Q4 24 | 29.8% | -0.3% | ||
| Q3 24 | 26.5% | 3.8% | ||
| Q2 24 | 30.9% | 1.2% |
| Q1 26 | $0.37 | — | ||
| Q4 25 | $0.44 | $0.23 | ||
| Q3 25 | $0.39 | $0.30 | ||
| Q2 25 | $0.32 | $0.28 | ||
| Q1 25 | $0.32 | $0.25 | ||
| Q4 24 | $0.35 | $-0.02 | ||
| Q3 24 | $0.31 | $0.23 | ||
| Q2 24 | $0.36 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $93.9M |
| Total DebtLower is stronger | $154.9M | — |
| Stockholders' EquityBook value | $1.6B | $161.6M |
| Total Assets | $12.3B | $261.1M |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $93.9M | ||
| Q3 25 | — | $95.6M | ||
| Q2 25 | — | $81.3M | ||
| Q1 25 | — | $86.5M | ||
| Q4 24 | — | $84.7M | ||
| Q3 24 | — | $78.7M | ||
| Q2 24 | — | $68.7M |
| Q1 26 | $154.9M | — | ||
| Q4 25 | $261.7M | — | ||
| Q3 25 | $262.1M | — | ||
| Q2 25 | $262.4M | — | ||
| Q1 25 | $262.7M | — | ||
| Q4 24 | $263.0M | — | ||
| Q3 24 | $136.3M | — | ||
| Q2 24 | $136.6M | — |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $161.6M | ||
| Q3 25 | $1.5B | $166.7M | ||
| Q2 25 | $1.5B | $163.7M | ||
| Q1 25 | $1.4B | $167.1M | ||
| Q4 24 | $1.4B | $161.0M | ||
| Q3 24 | $1.4B | $162.6M | ||
| Q2 24 | $1.4B | $156.4M |
| Q1 26 | $12.3B | — | ||
| Q4 25 | $12.3B | $261.1M | ||
| Q3 25 | $12.3B | $264.8M | ||
| Q2 25 | $12.2B | $254.9M | ||
| Q1 25 | $11.8B | $252.7M | ||
| Q4 24 | $11.6B | $240.9M | ||
| Q3 24 | $12.0B | $245.3M | ||
| Q2 24 | $11.6B | $235.8M |
| Q1 26 | 0.10× | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.18× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $187.5M | $9.9M | ||
| Q3 25 | $49.5M | $18.5M | ||
| Q2 25 | $30.4M | $4.3M | ||
| Q1 25 | $55.9M | $2.6M | ||
| Q4 24 | $129.5M | $12.2M | ||
| Q3 24 | $53.6M | $9.6M | ||
| Q2 24 | $22.7M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | $171.5M | $7.6M | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | $113.9M | $10.0M | ||
| Q3 24 | — | $7.9M | ||
| Q2 24 | — | $-2.0M |
| Q1 26 | — | — | ||
| Q4 25 | 124.3% | 6.1% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | 94.6% | 8.5% | ||
| Q3 24 | — | 6.9% | ||
| Q2 24 | — | -1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | 1.9% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | 12.9% | 1.9% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.18× | 2.41× | ||
| Q3 25 | 1.20× | 3.46× | ||
| Q2 25 | 0.91× | 0.81× | ||
| Q1 25 | 1.71× | 0.55× | ||
| Q4 24 | 3.61× | — | ||
| Q3 24 | 1.67× | 2.21× | ||
| Q2 24 | 0.61× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FCF
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
